• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eurosurv. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017

tetano

Editor, Senior Moderator
Eurosurveillance, Volume 22, Issue 14, 06 April 2017
Rapid communication

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017


LS Vestergaard [SUP]1[/SUP] , J Nielsen [SUP]1[/SUP] , TG Krause [SUP]1[/SUP] , L Espenhain [SUP]1[/SUP] , K Tersago [SUP]2[/SUP] , N Bustos Sierra [SUP]2[/SUP] , G Denissov [SUP]3[/SUP] , K Innos [SUP]3[/SUP] , MJ Virtanen [SUP]4[/SUP] , A Fouillet [SUP]5[/SUP] , T Lytras [SUP]6[/SUP] , A Paldy [SUP]7[/SUP] , J Bobvos [SUP]7[/SUP] , L Domegan [SUP]8[/SUP] , J O?Donnell [SUP]8[/SUP] , M Scortichini [SUP]9[/SUP] , A de Martino [SUP]10[/SUP] , K England [SUP]11[/SUP] , N Calleja [SUP]11[/SUP] , L van Asten [SUP]12[/SUP] , AC Teirlinck [SUP]12[/SUP] , R T?nnessen [SUP]13[/SUP] , RA White [SUP]13[/SUP] , S P Silva [SUP]14[/SUP] , AP Rodrigues [SUP]14[/SUP] , A Larrauri [SUP]15[/SUP] , I Leon [SUP]15[/SUP] , A Farah [SUP]16[/SUP] , C Junker [SUP]17[/SUP] , M Sinnathamby [SUP]18[/SUP] , RG Pebody [SUP]18[/SUP] , A Reynolds [SUP]19[/SUP] , J Bishop [SUP]19[/SUP] , D Gross [SUP]20[/SUP] , C Adlhoch [SUP]21[/SUP] , P Penttinen [SUP]21[/SUP] , K M?lbak [SUP]1[/SUP]
+ Author affiliations
1. Statens Serum Institut, Copenhagen, Denmark
2. Scientific Institute of Public Health, Brussels, Belgium
3. National Institute for Health Development, Tallinn, Estonia
4. National Institute for Health and Welfare, Helsinki, Finland
5. French Public Health Agency (Sant? Publique France), Saint-Maurice, France
6. Hellenic Centre for Disease Control and Prevention, Athens, Greece
7. National Public Health Center, Budapest, Hungary
8. Health Service Executive - Health Protection Surveillance Centre, Dublin, Ireland
9. Dipartimento Epidemiologia del S.S.R., Lazio ? ASL Roma 1, Rome, Italy
10. Ministero della Salute, Rome, Italy
11. Ministry of Health, Pieta, Malta
12. National Institute of Public Health and the Environment (RIVM), The Netherlands
13. Norwegian Institute of Public Health, Oslo, Norway
14. Instituto Nacional de Sa?de Doutor Ricardo Jorge, Lisbon, Portugal
15. CIBER Epidemiolog?a y Salud P?blica (CIBERESP) Instituto de Salud Carlos III, Madrid, Spain
16. The Public Health Agency of Sweden, Stockholm, Sweden
17. Federal Statistical Office, Neuch?tel, Switzerland
18. Public Health England, Colindale, United Kingdom
19. Health Protection Scotland, Glasgow, United Kingdom
20. WHO Regional Office for Europe, Copenhagen, Denmark
21. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden


Correspondence: Lasse S Vestergaard (lav@ssi.dk)








Citation style for this article: Vestergaard LS, Nielsen J, Krause TG, Espenhain L, Tersago K, Bustos Sierra N, Denissov G, Innos K, Virtanen MJ, Fouillet A, Lytras T, Paldy A, Bobvos J, Domegan L, O?Donnell J, Scortichini M, de Martino A, England K, Calleja N, van Asten L, Teirlinck AC, T?nnessen R, White RA, P Silva S, Rodrigues AP, Larrauri A, Leon I, Farah A, Junker C, Sinnathamby M, Pebody RG, Reynolds A, Bishop J, Gross D, Adlhoch C, Penttinen P, M?lbak K. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Euro Surveill. 2017;22(14):pii=30506. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.14.30506

Received:10 March 2017; Accepted:06 April 2017

[h=4][/h]
Since December 2016, excess all-cause mortality was observed in many European countries, especially among people aged ≥ 65 years. We estimated all-cause and influenza-attributable mortality in 19 European countries/regions. Excess mortality was primarily explained by circulation of influenza virus A(H3N2). Cold weather snaps contributed in some countries. The pattern was similar to the last major influenza A(H3N2) season in 2014/15 in Europe, although starting earlier in line with the early influenza season start.

full text

http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=22766
 
Back
Top Bottom